STAT China Jonathan Chan STAT Plus: Legend Biotech believes it is not a target of Chinese investigation, CEO says
STAT China Jonathan Chan STAT China: Lineup for Hong Kong IPO grows, and a conversation with Junshi’s Li Ning
STAT China Jonathan Chan STAT China: A debut for CanSino Biologics and Cellular BioMed’s controversy
STAT China Jonathan Chan STAT China: Big news at Simcere, and a breakthrough designation for Legend Biotech
